Detalhe da pesquisa
1.
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
Lancet Oncol
; 24(2): 151-161, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681091
2.
Overcoming the hurdles: surmounting acquired resistance to anti-EGFR therapy in metastatic colorectal cancer.
Clin Adv Hematol Oncol
; 21(11): 572-583, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37948593
3.
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.
Oncologist
; 27(3): 198-209, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274710
4.
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series.
Oncologist
; 26(1): 7-16, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852072
5.
Molecular Profiling in Metastatic Colorectal Cancer.
Oncology (Williston Park)
; 34(9): 352-355, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965665
6.
Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors.
Oncologist
; 24(3): 319-326, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30018131
7.
Colon Cancer in Young Adults: Trends and Their Implications.
Curr Oncol Rep
; 21(1): 3, 2019 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30659375
8.
Biomarkers for immune therapy in gastrointestinal cancers.
Clin Adv Hematol Oncol
; 17(2): 109-119, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30845114
9.
Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be Enough.
Oncologist
; 23(10): 1171-1177, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29703766
10.
Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary Cancers.
Oncologist
; 22(2): 152-157, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28193735
11.
The Growing Challenge of Young Adults With Colorectal Cancer.
Oncology (Williston Park)
; 31(5): 381-9, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28516436
12.
Precision Medicine in Metastatic Colorectal Cancer: Relevant Carcinogenic Pathways and Targets-PART 1: Biologic Therapies Targeting the Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor.
Oncology (Williston Park)
; 31(7): 539-48, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28712098
13.
Precision Medicine in Metastatic Colorectal Cancer: Relevant Carcinogenic Pathways and Targets-PART 2: Approaches Beyond First-Line Therapy, and Novel Biologic Agents Under Investigation.
Oncology (Williston Park)
; 31(7): 573-80, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28712102
14.
Evolving standards of care for resected pancreatic cancer.
Clin Adv Hematol Oncol
; 15(2): 141-150, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28398285
15.
Trifluridine/tipiracil and regorafenib: new weapons in the war against metastatic colorectal cancer.
Clin Adv Hematol Oncol
; 14(8): 630-8, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27487107
16.
A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancer.
Clin Adv Hematol Oncol
; 14(2): 116-28, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27057810
17.
Current Standards and Novel Treatment Options for Metastatic Pancreatic Adenocarcinoma.
Oncology (Williston Park)
; 29(11): 809-20, 886, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26573060
18.
Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail.
NPJ Precis Oncol
; 8(1): 85, 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38582894
19.
Evolving Standards of Care in the Management of Localized Colorectal Cancer.
Am Soc Clin Oncol Educ Book
; 44(3): e432034, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768426
20.
Phase 1 Study of Hypofractionated Proton Beam Radiation Therapy in Adjuvant Pancreatic Cancer (PROTON-PANC).
Int J Radiat Oncol Biol Phys
; 118(2): 362-367, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37717786